Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.
Xavier Ayrignac
,
Clarisse Carra Dallière
,
Nicolas Menjot de Champfleur
,
Christian Denier
,
Patrick Aubourg
et al.
Journal articles
hal-01138578v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Assessing the experience of the quality of care of patients living with multiple sclerosis and their caregivers: the MusiCare Questionnaire
David Veillard
,
Karine Baumstarck
,
Gilles Edan
,
Marc Debouverie
,
Sandrine Wiertlewski
et al.
Journal articles
hal-03101922v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Effects of High and Low Efficacy Therapy in Secondary Progressive Multiple Sclerosis
Izanne Roos
,
Emmanuelle Leray
,
Romain Casey
,
Dana Horakova
,
Eva Havrdova
et al.
Journal articles
hal-03282036v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference
Antoine Gavoille
,
Fabien Rollot
,
Romain Casey
,
Marc Debouverie
,
Emmanuelle Le Page
et al.
Journal articles
hal-03963580v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Izanne Roos
,
Charles Malpas
,
Emmanuelle Leray
,
Romain Casey
,
Dana Horakova
et al.
Journal articles
hal-03776286v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study
D. A. Laplaud
,
L. Barbin
,
Chloé Rousseau
,
N. Jousset
,
Romain Casey
et al.
Multiple Sclerosis Journal , 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.62--63
Journal articles
hal-01259392v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal
Fabien Rollot
,
Justine Couturier
,
Romain Casey
,
Sandrine Wiertlewski
,
Marc Debouverie
et al.
Journal articles
hal-03594074v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study
Laetitia Barbin
,
Chloé Rousseau
,
Natacha Jousset
,
Romain Casey
,
Marc Debouverie
et al.
Journal articles
hal-01299977v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Geographical Heterogeneity of Multiple Sclerosis Prevalence in France
Diane Pivot
,
Marc Debouverie
,
Michel Grzebyk
,
David Brassat
,
Michel Clanet
et al.
Journal articles
inserm-01576154v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: A multicentre study
Noëlle Lavandier
,
Mickaël Bonnan
,
Clarisse Carra-Dallière
,
Mahmoud Charif
,
Pierre Labauge
et al.
Journal articles
hal-02928079v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome
Christine Lebrun-Frénay
,
Fabien Rollot
,
Lydiane Mondot
,
Helene Zephir
,
Celine Louapre
et al.
Journal articles
hal-03414579v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Cognition and quality of life in clinically isolated syndrome patients starting a disease modifying therapy in the QUALICIS study may not predict treatment response at one year
M. Cohen
,
Bruno Brochet
,
Pierre Clavelou
,
Emmanuelle Le Page
,
Patrick Vermersch
et al.
Journal articles
hal-01614698v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Determinants of Therapeutic Lag in Multiple Sclerosis
Izanne Roos
,
Emmanuelle Leray
,
Federico Frascoli
,
Romain Casey
,
J William L Brown
et al.
Journal articles
hal-03223056v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
David-Axel Laplaud
,
Romain Casey
,
Laetitia Barbin
,
Marc Debouverie
,
Jerome de Sèze
et al.
Journal articles
inserm-02289153v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society
C. Lebrun
,
S. Vukusic
,
V. Abadie
,
C. Achour
,
F. Ader
et al.
Journal articles
hal-02546158v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
High and low efficacy therapy in secondary progressive multiple sclerosis after accounting for therapeutic lag
I. Roos
,
Emmanuelle Leray
,
Romain Casey
,
D. Horakova
,
E. Kubala Havrdova
et al.
Multiple Sclerosis Journal , 2020, 26 (3_SUPPL), pp.534-535
Journal articles
hal-03127244v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Untreated patients with multiple sclerosis: A study of French expert centers
Xavier Moisset
,
Audrey-Anne Fouchard
,
Bruno Pereira
,
Frederic Taithe
,
Guillaume Mathey
et al.
Journal articles
hal-03188971v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study
Sarah Wilson
,
Floriane Calocer
,
Fabien Rollot
,
Mathieu Fauvernier
,
Laurent Remontet
et al.
Journal articles
hal-03875120v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies
Johanna Andersen
,
Sifat Sharmin
,
Mathilde Lefort
,
Nils Koch-Henriksen
,
Finn Sellebjerg
et al.
Journal articles
hal-03268539v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament-light chain in multiple sclerosis
Audrey Gauthier
,
Sébastien Viel
,
Magali Perret
,
Guillaume Brocard
,
Romain Casey
et al.
Journal articles
hal-03216866v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Aquaporin 4 distribution in the brain and its relevance for the radiological appearance of neuromyelitis optica spectrum disease
Roxana Ameli
,
Charles R.G. Guttmann
,
Juan Carlos Prieto
,
Fabien Rollot
,
Miklos Palotai
et al.
Journal articles
hal-03538467v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study
Caroline Papeix
,
Giovanni Castelnovo
,
Emmanuelle Leray
,
Marc Coustans
,
Pierre Levy
et al.
Journal articles
hal-03608016v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Delay from treatment start to full effect of immunotherapies for multiple sclerosis
Izanne Roos
,
Emmanuelle Leray
,
Federico Frascoli
,
Romain Casey
,
J William L Brown
et al.
Journal articles
hal-02955197v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
Sifat Sharmin
,
Mathilde Lefort
,
Johanna Balslev Andersen
,
Emmanuelle Leray
,
Dana Horakova
et al.
Journal articles
hal-03367246v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
Sophie Mathais
,
Xavier Moisset
,
Bruno Pereira
,
Frederic Taithe
,
Jonathan Ciron
et al.
Journal articles
hal-02995967v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions
Stephane Kremer
,
Salem Hannoun
,
Fabrice Bonneville
,
Francoise Durand-Dubief
,
Thomas Tourdias
et al.
Journal articles
hal-02570313v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study
Emmanuelle Leray
,
Sandra Vukusic
,
Marc Debouverie
,
Michel Clanet
,
Bruno Brochet
et al.
Journal articles
hal-01201656v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
A French observational study about treatment failure under fingolimod in 91 multiple sclerosis patients
Clarisse Carra Dallière
,
M. Fisselier
,
M. Cohen
,
X. Ayrignac
,
Emmanuelle Le Page
et al.
Multiple Sclerosis Journal , 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.701--702
Journal articles
hal-01259397v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Données IRM à long terme des patients sous tériflunomide : résultats de l’extension de l’étude de phase II
David K.B. Li
,
Anthony L. Traboulsee
,
Philippe Truffinet
,
Paul W. O’connor
,
Jean Pelletier
et al.
Conference papers
hal-01134975v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
MD1003 (high doses of biotin) in progressive multiple sclerosis: subgroup analyses of the MS-SPI trial
Ayman Tourbah
,
Christine Lebrun-Frenay
,
Gilles Edan
,
M. Clanet
,
C. Papex
et al.
Multiple Sclerosis Journal , 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.785
Journal articles
hal-01259396v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More